Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Medifast, Inc. (NYSE: MED)
MED Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-13.50%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
-51%
MED Stock Analysis
MED
PE Ratio:
MED
PEG Ratio:
Not Available
MED
Forward EPS Growth (12 month):
0.00%
MED
PS Ratio:
0.4
MED
PSG Ratio:
MED
Forward Revenue Growth (12 month):
-8.50%
MED Articles
No data was found